logo
episode-header-image
Sep 2025
22m 31s

Wary pharma: AstraZeneca sours on UK

The Economist
About this episode
tail spinning
Up next
Yesterday
Omission accomplished: why the Iran-war cycle spins on
From impasse in Iran to still-unresolved conflicts in Gaza and Lebanon, a trend is clear: President Donald Trump’s scant, early plans for peace do not actually forge a path to it. Our correspondent says that in the driverless-car future, it will often be Chinese AI behind the whe ... Show More
25m 39s
Jul 30
Working memory: the surprising decline of dementia
A dive into the data reveals that, despite dire past predictions, the prevalence of dementia is actually waning. We take a look at Pix, a beloved Brazilian digital-payments system, and why it so bothers President Donald Trump. And we attend one of the concerts that reveals how th ... Show More
25m 8s
Jul 29
Brave New whirl: Turkey’s opposition overhaul
An ousted former opposition leader started a new party—called the New Party. We assess its chances at the ballot box, and under President Recep Tayyip Erdogan’s thumb. A surrogacy scandal in Germany has prompted a government reshuffle, with Chancellor Friedrich Merz left holding ... Show More
20m 27s
Recommended Episodes
Sep 2025
Wary pharma: AstraZeneca sours on UK
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ... Show More
22m 31s
Apr 2021
AZ Good as it Gets?
An AstraZeneca vaccine trial on children gets put on pause while a possible link with rare blood clots is investigated. And former Bank of England governor, Mark Carney, talks climate change, fintech and... should Adam sell his Bitcoin? Today’s Newscast was made by Sam Bonham wit ... Show More
32m 39s
Jun 2023
AstraZeneca could spin off China business
<p>AstraZeneca has drawn up plans to break out its China business, and&nbsp;France is challenging a German-led plan to build up Europe’s air defences. Plus, US businesses are cutting back on their investments in diversity and inclusion.&nbsp;</p><br><p><strong>Mentioned in this p ... Show More
8m 9s
Apr 2020
The search for a remedy
As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ... Show More
20m 17s
Sep 2024
Who audits the auditors?
<p>The UK blocks some arms shipments to Israel, audit firms are fighting against new oversight rules in the US, and the same technology that brought us Covid-19 vaccines could also be used to fight cancer. Plus, the Oasis revival tour is so popular it triggered a UK investigation ... Show More
10m 39s
Sep 2023
Xi 'Has His Hands Full', UK-China Spying & Far Right Strength In Europe
<p>On today's podcast:<br>(1) President Biden says China's economic challenges make a Taiwan invasion unlikely.</p> <p>(2) The UK's Prime Minister confronts the Chinese premier over a Parliamentary spying arrest.</p> <p>(3) Costs for UK tenants expected to soar by a quarter over ... Show More
16m 36s
May 2023
US sues to block drug merger
<p>The Federal Trade Commission sued to block the biotechnology company Amgen’s $28.3bn deal to acquire Horizon Therapeutics, Italy is struggling to spend €200bn in EU Covid recovery funds, and Ukraine said it repelled an unprecedented barrage of Russian missiles over Kyiv.&nbsp; ... Show More
9m 43s
Mar 2021
EU countries to restart AstraZeneca use, Biden's hardline on China, airline lift-off
<p>Europe’s biggest countries are set to resume using the Oxford/AstraZeneca coronavirus vaccine after the EU drugs regulator said the jab was safe, and the US is taking a tough stance as members from the Biden administration meet with Chinese officials in Alaska. Plus, the FT’s ... Show More
10m 31s
Oct 2021
Sick Money (Pt 2): How Big Pharma made a killing from the pandemic
The second of two episodes this week, taking a deep dive into the pharmaceutical industry.Big drug companies have won plaudits for their work producing Covid vaccines within a year of the start of the pandemic. How much money are they making from them? And why are vaccines for ot ... Show More
24m 39s